Common MSK problems
Common Symptoms
Prevention
Palliative Care
Psych
100

Anterior knee pain after prolonged sitting, running, climbing 

Patellofemoral pain syndrome

100

Recurrent brief vertigo worsened by positional changes

Benign paroxysmal positional vertigo

100

USPSTF criteria for stating statin therapy for primary prevention of ASCVD

Adults aged 40 to 75 with > 1 ASCVD risk factor and a 10-year ASCVD risk > 10%

100

Timing of palliative medicine initiation for incurable/advanced disease

At time of diagnosis

100

Initial treatment of OCD

CBT

200

Posterior swelling and tenderness of elbow with normal range of motion

Olecranon bursitis 

200

Syncope preceded by nausea and diaphoresis in a healthy person

Neurally mediated (vasovagal) syndrome

200

Primary management of hypertriglyceridemia 

Lifestyle changes
200

Contraindication to initiating a long-acting opioid

Opioid-naive patient

200

Chaotic interpersonal relationships, emotional lability, self-destructive behaviors

Borderline personality disorder

300

Lateral knee pain proximal to lateral femoral condyle after exercise

Iliotibial band syndrome

300

Test for all patients with syncope

EKG

300
Indication for exercise stress testing for evaluation of syncope

Exertional syncope

300

Official recommendation on whether enteral/parenteral nutritional support should be started at the end of life  

Avoid

300

Risk of prescribing antidepressant monotherapy in bipolar disorder

Precipitation of a manic episode

400

Lateral hip pain of insidious onset, worse with climbing stairs and lying on side

Greater trochanteric pain syndrome

400

Urine leakage with coughing, sneezing, laughing

Stress urinary incontinence 

400

First nonstatin options added to maximal statin therapy for secondary ASCVD prevention in patients at very high risk

Ezetimibe and/or PCSK9 monoclonal antibodies

400

Initial class of drugs used for radiation-induced vomiting

Serotonin antagonists (ondansetron, granisetron)

400

Recurrence criteria for long-term depression drug therapy

≥3 episodes of major depressive disorder


500

Arm paresthesias/pain worsened with activity and arm elevation

Neurogenic thoracic outlet syndrome

500

Initial drug therapy for allergic rhinitis-associated upper airway cough syndrome (UACS)

Intranasal glucocorticoids 

500

USPSTF recommendation for peripartum depression prevention in at-risk patients

CBT or interpersonal therapy

500

Rapid-acting depression treatment useful at the end of life 

Methylphenidate 

500

First-line drugs for alcohol dependence

Naltrexone and acamprosate